For the quarter ending 2025-12-31, BTCY had -$18,966 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Effect of exchange rate changes on cash | -33,137 | -26,883 | - |
| Property, plant and equipment | - | 0 | - |
| Net loss | -717,067 | -690,913 | -671,977 |
| Net cash used in investing activities | - | 0 | - |
| Stock based compensation | 6,001 | 6,001 | 5,935 |
| Issuance of shares for services | 3,770 | 0 | - |
| Issuance of warrants for services, at fair value | 38,078 | - | - |
| Accretion and amortization expenses | -185,470 | -202,141 | -153,572 |
| Non cash lease expense | - | 114,503 | 110,870 |
| Change in fair value of derivative liabilities | -134,335 | -8,771 | -25,200 |
| Loss (gain) on debt and share conversion and redemption | 7,181 | 0 | -8,433 |
| Property, plant and equipment depreciation | 1,488 | 1,489 | 1,488 |
| Right of use assets amortization | 343,626 | - | - |
| Accounts receivable, net | -482,337 | 248,101 | 205,418 |
| Issuance of shares for services | - | - | 0 |
| Inventory | -281,531 | 472,863 | 228,041 |
| Deposits and other receivables | 299,435 | -236,687 | 49,117 |
| Advance from customers | -1,150,000 | 1,895,920 | - |
| Accounts payable and accrued liabilities | 167,767 | -638,005 | 492,532 |
| Issuance of preferred shares, net | - | 0 | 0 |
| Net cash generated (used) in operating activities | -740,291 | 415,630 | -373,389 |
| Issuance of common shares, net | - | 0 | 0 |
| Redemption of preferred shares | 0 | 200,000 | - |
| Proceeds from (repayment to) convertible debentures, net | -77,003 | 0 | - |
| Proceeds from (repayment to) short term loan and promissory notes, net | 804,328 | 298,367 | 441,623 |
| Term loan, net | 0 | 600,000 | - |
| Preferred stock dividend | 6,000 | 12,033 | 5,918 |
| Net cash provided (used) in financing activities | 721,325 | -507,748 | 435,705 |
| Net decrease in cash during the period | -18,966 | -92,118 | 62,316 |
| Cash and cash equivalents at beginning of period | 308,460 | 365,145 | - |
| Cash and cash equivalents at end of period | 256,357 | 308,460 | - |
BIOTRICITY INC. (BTCY)
BIOTRICITY INC. (BTCY)